Joseph V. Penn

Psychiatric Disorders and Repeat Incarcerations: The Revolving Prison Door

OBJECTIVE A number of legal, social, and political factors over the past 40 years have led to the current epidemic of psychiatric disorders in the U.S. prison system. Although numerous investigations have reported substantially elevated rates of psychiatric disorders among prison inmates compared with the general population, it is unclear whether mental illness is a risk factor for multiple episodes of incarceration. The authors examined this association in a retrospective cohort study of the nations largest state prison system. METHOD The study population included 79,211 inmates who began serving a sentence between September 1, 2006, and August 31, 2007. Data on psychiatric disorders, demographic characteristics, and history of incarceration for the preceding 6-year period were obtained from statewide medical information systems and analyzed. RESULTS Inmates with major psychiatric disorders (major depressive disorder, bipolar disorders, schizophrenia, and nonschizophrenic psychotic disorders) had substantially increased risks of multiple incarcerations over the 6-year study period. The greatest increase in risk was observed among inmates with bipolar disorders, who were 3.3 times more likely to have had four or more previous incarcerations compared with inmates who had no major psychiatric disorder. CONCLUSIONS Prison inmates with major psychiatric disorders are more likely than those without to have had previous incarcerations. The authors recommend expanding interventions to reduce recidivism among mentally ill inmates. They discuss the potential benefits of continuity of care reentry programs to help mentally ill inmates connect with community-based mental health programs at the time of their release, as well as a greater role for mental health courts and other diversion strategies.

Addressing the Challenge of Community Reentry Among Released Inmates with Serious Mental Illness

The purpose of the paper is to discuss the formidable challenges to community reentry and reintegration faced by U.S. prison inmates with serious mental illness and to describe various strategies for improving transitional services for these individuals. We review epidemiologic data supporting the high prevalence of severe mental illness in U.S. prisons as well as the historical factors underlying the criminalization of the mentally ill. The importance and challenges of providing adequate psychiatric care for mentally ill prisoners during their incarceration are discussed. We also review the numerous psychosocial and economic challenges confronting these individuals upon their release from prison, such as unemployment and vulnerability to homelessness, as well as specific barriers they may encounter in attempting to access community-based mental health services. We follow with a discussion of some of the more promising strategies for improving the transition of the mentally ill from prison to the community. In the final sections, we review the evidence for a relationship between serious mental illness and recidivism and briefly discuss emerging alternatives to incarceration of the mentally ill.

Risk of Reincarceration Among Prisoners with Co-occurring Severe Mental Illness and Substance Use Disorders

This study examined whether the presence of a comorbid substance use disorder increased the risk of criminal recidivism and reincarceration in prison inmates with a severe mental illness. Our analyses of more than 61,000 Texas prison inmates showed that those with a co-occurring psychiatric and substance use disorder exhibited a substantially higher risk of multiple incarcerations over a 6-year period compared to inmates with psychiatric disorders alone or substance use disorders alone. Further research is needed to identify the factors associated with criminal recidivism among released prisoners with co-occurring disorders.

Bupropion Diversion and Misuse in the Correctional Facility

The antidepressant bupropion plays an important role in the treatment of mental health disorders. It is well known that incarcerated individuals are at increased risk of experimenting with psychiatric medications and it is imperative for prescribers and clinicians to understand the misuse potential of these medications, including bupropion. The mechanism of reinforcement of misuse of bupropion is related to the effect on dopamine and norepinephrine neurotransmitter systems. When bupropion is crushed and ingested via nasal insufflation, a faster and higher affinity for neurotransmitters occurs, heightening the misuse potential. A literature search and illustrative case studies are presented demonstrating the misuse potential, along with a review of the clinical implications. This article concludes that in the incarcerated population, bupropion is a medication with significant misuse and diversion potential.

Prevalence of Psychiatric Disorders in the Texas Juvenile Correctional System

Most studies assessing the burden of psychiatric disorders in juvenile correctional facilities have been based on small or male-only samples or have focused on a single disorder. Using electronic data routinely collected by the Texas juvenile correctional system and its contracted medical provider organization, we estimated the prevalence of selected psychiatric disorders among youths committed to Texas juvenile correctional facilities between January 1, 2004, and December 31, 2008 (N = 11,603). Ninety-eight percent were diagnosed with at least one of the disorders. Highest estimated prevalence was for conduct disorder (83.2%), followed by any substance use disorder (75.6%), any bipolar disorder (19.4%), attention-deficit/hyperactivity disorder (18.3%), and any depressive disorder (12.6%). The estimated prevalence of psychiatric disorders among these youths was exceptionally high and showed patterns by sex, race/ethnicity, and age that were both consistent and inconsistent with other juvenile justice samples.

Psychoactive Medication Misadventuring in Correctional Health Care.

Due to multiple factors, unprecedented numbers of individuals with mental health disorders and many with comorbid substance use disorders are now incarcerated in jails and prisons. This article details a variety of medication use and potential abuse/misuse/misadventuring topics that are unique to the correctional health care setting, with emphasis on how the large number of persons with psychiatric and/or substance use disorders affects these issues and methods that correctional systems commonly use to manage these inmate-patients. Also discussed are the potential for inmate feigning or malingering as a goal-directed behavior, potential for misadventuring/abuse of commonly used medications, urine drug screening/surveillance, and the effect of psychoactive medications on heat tolerance and environmental issues.

The changing epidemiology of HIV in the criminal justice system

Although the rate of HIV infection among US prison inmates is considerably higher than that of the general population, little is known about age-related changes in HIV-infected inmates over the last decade. This study of the nation’s largest state prison system examined (1) whether the mean age of the HIV-infected inmate increased over the last decade, and (2) whether the prevalence of HIV and associated comorbidities varied according to age. The study population included all 230,103 inmates incarcerated in the Texas prison system for any duration during 2014. A separate analysis was conducted on all HIV-infected inmates incarcerated between 2004 and 2014. Information on medical conditions and demographic factors was obtained from an institution-wide electronic medical record system. From 2004 to 2014, the mean age of HIV-infected inmates in the prison system increased from 39.3 to 42.5 years, compared to an increase of 36.1–37.9 for all Texas prison inmates. Multivariable logistic regression was used to assess the independent contributions of multiple demographic and clinical covariates in predicting the binary outcome, HIV infection. The model showed that, in 2014, HIV infection was elevated in inmates who were aged 40–49 years (OR = 3.1; 95% CI 2.7–3.3), aged 50–59 years (OR = 2.4; 95% CI 2.1–2.7), African American (OR = 3.0; 95% CI 2.8–3.3), and in those with several chronic diseases, including chronic obstructive pulmonary disease (OR = 1.7; 95% CI 1.5–1.9), hepatitis C (OR = 2.7; 95% CI 2.5–3.1), major depressive disorder (OR = 1.7; 95% CI 1.5–2.1), bipolar disorder (OR = 2.3; 95% CI 1.8–2.8), and schizophrenia (OR = 1.5; 95% CI 1.3–1.8). Among HIV-infected inmates (n = 2960), the percentage with comorbid disease increased in a linear fashion according to age (p < .01). Correctional health systems must adapt to address the evolving epidemiology of HIV among inmate populations.